ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,459Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 783

$910K Total Retail Price of All Prescriptions

Rank: 64 out of 783

599 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 13,909 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 582 469 S3 1 2
LEVOTHYROXINE SODIUM 543 472 2 1
PRAVASTATIN SODIUM 532 471 3 14
LISINOPRIL 518 454 4 4
FUROSEMIDE 444 377 5 7
OMEPRAZOLE 430 345 6 6
SIMVASTATIN 362 327 7 3
METOPROLOL TARTRATE 361 342 8 9
WARFARIN SODIUM 327 291 9 10
CARVEDILOL 265 241 10 21
METFORMIN HCL 256 182 11 8
SERTRALINE HCL 249 207 12 22
POTASSIUM CHLORIDE 208 176 13 16
BENAZEPRIL HCL 204 184 14 85
ALENDRONATE SODIUM 200 187 15 25
KLOR-CON M20 196 153 16 48
ATORVASTATIN CALCIUM 190 180 17 11
FLUOXETINE HCL 182 143 18 45
ATENOLOL 179 149 19 17
METOPROLOL SUCCINATE 179 168 19 13
AMLODIPINE BESYLATE 174 141 21 5
GABAPENTIN 174 142 21 15
DONEPEZIL HCL 164 158 23 24
EVISTA 164 155 23 92
TRIAMTERENE-HCTZ 163 141 25 42
CLOPIDOGREL 160 138 26 29
NEXIUM 159 131 27 28
LOVASTATIN 151 123 28 58
TRAMADOL HCL 139 127 29 20
GLIMEPIRIDE 132 120 30 34
ALLOPURINOL 130 130 31 31
DIGOXIN 124 124 32 61
HYDROCHLOROTHIAZIDE 123 103 33 12
LANTUS 121 98 34 38
TAMSULOSIN HCL 121 92 34 26
CITALOPRAM HBR 116 103 36 19
NAMENDA 115 103 37 32
FENOFIBRATE 114 98 38 66
OXYBUTYNIN CHLORIDE ER 111 104 39 117
PLAVIX 102 91 40 51
DILTIAZEM 24HR ER 98 96 41 122
ZOLPIDEM TARTRATE 97 67 42 23
SPIRIVA 97 87 42 59
ADVAIR DISKUS 94 80 44 50
DILTIAZEM 24HR CD 93 89 45 118
PREDNISONE 92 82 46 36
CYMBALTA 88 73 47 35
ROPINIROLE HCL 88 51 47 74
POLYETHYLENE GLYCOL 3350 87 73 49 43
FAMOTIDINE 87 75 49 55
SULFAMETHOXAZOLE-TRIMETHOPRIM 87 76 49 95
TRAZODONE HCL 85 62 52 39
FLUTICASONE PROPIONATE 84 64 53 46
ISOSORBIDE MONONITRATE ER 83 83 54 40
JANUVIA 82 80 55 73
LOSARTAN POTASSIUM 79 65 56 18
PROAIR HFA 77 43 57 56
PANTOPRAZOLE SODIUM 77 75 57 30
PRAMIPEXOLE DIHYDROCHLORIDE 76 59 59 147
NOVOLOG 73 55 60 81
NABUMETONE 72 45 61 178
VERAPAMIL ER 69 69 62 119
RAMIPRIL 68 52 63 113
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 58 63 33
CIPROFLOXACIN HCL 63 54 65 62
RANITIDINE HCL 63 36 65 44
RISPERIDONE 59 51 67 67
OXYCODONE-ACETAMINOPHEN 57 39 S2 68 76
GLIPIZIDE 57 52 68 71
TRIMETHOPRIM 56 56 70 357
OXCARBAZEPINE 55 25 71 252
AMOXICILLIN 54 40 72 116
DOXYCYCLINE HYCLATE 54 52 72 112
LEVOFLOXACIN 54 47 72 75
ONGLYZA 54 54 72 240
CEPHALEXIN 52 44 76 70
ESTRADIOL 52 38 R 76 204
INSULIN SYRINGE 51 45 78 82
BUPROPION HCL SR 51 38 78 166
DILTIAZEM ER 51 50 78 153
VENLAFAXINE HCL ER 51 22 78 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.